Home > Protocol Summaries: Compounds > lacidipine Protocol Summaries: lacidipine GSKStudy ID Phase Title Status 106357 phase 4 A Randomized, Double-blind, Parallel Group, Single-Centre Study to Evaluate the Efficacy and Safety of Lacidipine and Amlodipine Once-daily Treatment in Hypertensive Adult Patients Completed LAC103842 phase 4 An open label, multi-centre, single arm phase IV study to evaluate the antihypertensive effect of Lacidipine in mild to moderate essential hypertension patients with Type 2 diabetes in Korea Completed
